Lee Jeongmin, Seo Yun-Soo, Lee A Yeong, Nam Hyeon-Hwa, Ji Kon-Young, Kim Taesoo, Lee Sanghyun, Hyun Jin Won, Moon Changjong, Cho Yongho, Jung Bokyung, Kim Joong Sun, Chae Sungwook
BK21 FOUR Program, College of Veterinary Medicine, Chonnam National University, Gwangju 61186, Republic of Korea.
Center for Companion Animal New Drug Development, Jeonbuk Branch, Korea Institute of Toxicology, Jeongeup 56212, Republic of Korea.
Pharmaceuticals (Basel). 2024 Feb 20;17(3):269. doi: 10.3390/ph17030269.
Georgi and Linne herbal mixture (SRE) is a Chinese herbal medicine. In this study, we aimed to evaluate the therapeutic efficacy of SRE as an active ingredient for 2,4-dinitrochlorobenzene (DNCB)-induced atopic dermatitis (AD) and to predict the underlying therapeutic mechanisms and involved pathways using network pharmacological analysis. Treatment with SRE accelerated the development of AD-like lesions, improving thickness and edema of the epidermis. Moreover, administering the SRE to AD-like mice suppressed immunoglobulin E and interleukin-4 cytokine and reduced T lymphocyte differentiation. In silico, network analysis was used to predict the exact genes, proteins, and pathways responsible for the therapeutic effect of the SRE against DNCB-induced AD. These results indicated that the SRE exerted protective effects on the DNCB-induced AD-like model by attenuating histopathological changes and suppressing the levels of inflammatory mediators. Therefore, the SRE can potentially be a new remedy for improving AD and other inflammatory diseases and predicting the intracellular signaling pathways and target genes involved. This therapeutic effect of the SRE on AD can be used to treat DNCB-induced AD and its associated symptoms.
Georgi和Linne草药混合物(SRE)是一种中药。在本研究中,我们旨在评估SRE作为活性成分对2,4-二硝基氯苯(DNCB)诱导的特应性皮炎(AD)的治疗效果,并使用网络药理学分析预测其潜在的治疗机制和涉及的途径。SRE治疗加速了AD样病变的发展,改善了表皮厚度和水肿。此外,给AD样小鼠施用SRE可抑制免疫球蛋白E和白细胞介素-4细胞因子,并减少T淋巴细胞分化。在计算机模拟中,网络分析用于预测SRE对DNCB诱导的AD治疗效果所涉及的确切基因、蛋白质和途径。这些结果表明,SRE通过减轻组织病理学变化和抑制炎症介质水平,对DNCB诱导的AD样模型发挥保护作用。因此,SRE有可能成为改善AD和其他炎症性疾病以及预测所涉及的细胞内信号通路和靶基因的新疗法。SRE对AD的这种治疗效果可用于治疗DNCB诱导的AD及其相关症状。